-
31
-
Ivabradine improves win ratios of heart failure outcomes in patients with reduced ejection fraction – insights from the <scp>SHIFT</scp> trial
-
Amr Abdin;
Saarraaken Kulenthiran;
Michel Komajda;
Jeffrey S. Borer;
Ian Ford;
Luigi Tavazzi;
Cécile Batailler;
Karl Swedberg;
Michael Böhm;
on behalf of the SHIFT Investigators;
Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine Saarland University Medical Center Homburg Germany;
Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine Saarland University Medical Center Homburg Germany;
Department of Cardiology Hospital Saint Joseph Paris France;
The Howard Gilman Institute for Heart Valve Diseases and Schiavone Institute for Cardiovascular Translational Research State University of New York Downstate Health Sciences University Brooklyn and New York NY USA;
Robertson Centre for Biostatistics University of Glasgow Glasgow UK;
Maria Cecilia Hospital, GVM Care &
amp, Research Cotignola Italy;
Institut de Recherches Internationales Servier Suresnes France;
Department of Molecular and Clinical Medicine University of Gothenburg Gothenburg Sweden;
Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine Saarland University Medical Center Homburg Germany;
;
(European Journal of Heart Failure,
v.,
2025,
)